NEW YORK / RankWire.AI / – In New York on Wednesday, U.S. equities experienced modest increases as yields on long-term Treasury bonds dropped sharply. The S&P 500 gained 16.22 points, or 0.21%, closing at 7,707.98, ending a streak of three consecutive declines. The Dow Jones Industrial Average rose by 119.65 points, or 0.22%, to finish at 53,463.05. Meanwhile, the Nasdaq Composite increased by 41.38 points, or 0.16%, closing at 26,331.09. The decline in government bond yields helped major indices recover after several sessions under pressure from rising borrowing costs.
Bond prices increased following the U.S. Treasury Department’s announcement of larger liquidity support buybacks for longer-dated government debt. Beginning September 9, the maximum purchase size will rise from $2 billion to at least $4 billion per operation. The update applies to nominal coupon securities within the 10-to-20-year and 20-to-30-year maturity ranges. These increased volumes will stay in effect through November 4. The department cited strong volumes of high-quality offers as the reason behind expanding liquidity operations in these sectors.
Following the announcement, Treasury yields declined, reversing some of the recent upward trend in long-term borrowing costs. The 10-year Treasury yield fell to approximately 4.65%, while the 30-year yield decreased to around 5.20%. Notably, the 30-year yield reached 5.337% on Tuesday, its highest level since 2007. Since bond yields move inversely to prices, increased demand for government debt pushed yields downward. This retreat alleviated some of the pressure caused by the recent selloff in longer-term government bonds.
Healthcare Sector Spurs Market Improvements
Wednesday’s session saw healthcare stocks bolster the overall market as several pharmaceutical companies posted significant gains. Moderna shares jumped 177%, while Merck advanced 12.6% after reporting positive outcomes from a Phase 3 melanoma trial. The INTerpath-001 study evaluated the personalized mRNA therapy intismeran autogene combined with Keytruda following surgical removal of high-risk melanoma. The trial met its primary endpoint for recurrence-free survival and also achieved a key secondary endpoint measuring survival without distant cancer spread.
This healthcare rally helped offset mixed trading in other sectors, especially within technology. Consumer-related stocks also contributed, following quarterly earnings reports from several major firms. Estée Lauder increased more than 16% after its earnings release, adding to gains in the consumer sector. Target and Lowe’s also rose after reporting their latest financial results. Smaller companies generally outperformed larger-cap indices, with the Russell 2000 advancing around 0.5% as the broader market recovered.
Indices End Three-Day Losing Streak
The upward move on Wednesday marked the end of a three-session decline for the Nasdaq, S&P 500, and Dow. The rebound followed earlier declines caused by rising long-term yields. Despite Wednesday’s gains, all three major indices remain lower for the week. The S&P 500 is about 1% below last Friday’s level, the Dow has decreased roughly 0.5%, and the Nasdaq is down approximately 1.5%.
Looking at the broader yearly performance, the markets remain in positive territory despite the recent downturn and bond market pressures. As of Wednesday’s close, the S&P 500 has gained around 12.6% since the start of the year, the Dow has increased approximately 11.2%, and the Nasdaq has outperformed with a rise of about 13.3%, reflecting its stronger year-to-date growth. Wednesday’s session represented a modest recovery for Wall Street, supported by lower Treasury yields and gains in the healthcare sector, lifting all three major U.S. stock indexes.